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Case ReportsAcute left ventricular failure after bilateral lung transplantation for
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Leuven, BelgiumVideo clip is available online.
We report a case of unexpected severe left ventricular
(LV) dysfunction in a patient undergoing a bilateral
lung transplant (BLTx). We attribute his complicated
postoperative course to diastolic dysfunction in a chroni-
cally deprived LV in combination with an increased pre-
load, caused by normalization of the pulmonary vascular
resistance (PVR), and an increased afterload during
weaning.
CLINICAL SUMMARY
After optimal medical treatment for 12 years, a 23-year-
old man with idiopathic pulmonary arterial hypertension
had deterioration to New York Heart Association functional
class III. Catheterization indicated elevated pulmonary arte-
rial pressure (PAP) values of 121 mm Hg systolic, 72 mm
Hg diastolic, and 89 mm Hg mean; a severely reduced car-
diac index of 1.63 L/(min $ m2); and a PVR of 2309 dynes
$ s $ cm5. In January 2012, the patient underwent an urgent
BLTx because of uncontrollable right ventricular failure
(Figure 1, A). Surgery was uneventful. After the operation,
PAP decreased to 30 mm systolic, 20 mm diastolic, and 22
mm Hg mean. PVR decreased to 204 dynes $ s $ cm5.
Oxygenation, hemodynamics, and chest radiography were
normal. Three hours after extubation, at the end of postop-
erative day 1, we observed high systemic pressure (150 mm
Hg systolic, 87 mm Hg diastolic, and 108 mm Hg mean),
cardiac index (5.3 L/[min $ m2]), and PAP (82 mm Hg sys-
tolic, 43 mm Hg diastolic, and 55 mm Hg mean). One hour
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achieved within 4 minutes. Echocardiography revealed
LV akinesia (Figure 1, B). Because of persistent hemody-
namic and respiratory instability, venoarterial extracorpo-
real membrane oxygenation was initiated. Within 36
hours, lactate level had normalized, pulmonary edema had
resolved, and epinephrine infusion was discontinued. On
postoperative day 6, transthoracic echocardiography con-
firmed LV recovery, and the extracorporeal membrane oxy-
genation was discontinued the same day. LV function
improved further and was normalized on postoperative
day 20, at which time the patient was discharged from the
intensive care unit. Five months after BLTx, cardiac and
pulmonary functions were acceptable.DISCUSSION
On the basis of the LVejection fraction on repeated trans-
thoracic echocardiography before BLTx, we were unable to
predict the complicated postoperative course of this patient.
In cases of pretransplant LV dysfunction, there is often a re-
lation to right ventricular dysfunction in patients with pul-
monary hypertension, possibly through ventricular
interdependence.1 Our patient, however, had a normal LV
ejection fraction (60%). Reperfusion edema, pulmonary re-
jection, and infection were considered unlikely causes for
the acute deterioration on the basis of the time course of
the deterioration (Figure 2), the absence of sputum, the clear
chest radiography, the stable saturation values before col-
lapse, and the severe LV dysfunction.
We believe that the mechanism leading to LV failure after
extubation was the normalization of preload in a chronically
preload-deprived LV. Normalization of the PVR through re-
placement of the entire pulmonary vascular bed must have
led to an increased LV preload, as well as a rightward shift
of the dyskinetic interventricular septum (Figure 1, B). The
LVof this young man, who had a history of PH since child-
hood, never had been exposed to such a preload before. LV
diastolic dysfunction emerged and came to full expression
with an increased afterload in the awake patient immedi-
ately after extubation.
A stroke volume of 34 mL, calculated from pretrans-
plant right heart catheterization, and a small LV
cavity on transthoracic echocardiography confirm our
hypothesis.ardiovascular Surgery c Volume 145, Number 1 e7
FIGURE 1. Echocardiographic images 1 month before bilateral lung transplant (BLTx; A), at collapse (B), and 1 month after lung transplant (C). LV, Left
ventricle; LVA (d), diastolic left ventricular area; LVA (s), systolic left ventricular area; RV, right ventricle; RVA (d), diastolic right ventricular area; RVA (s),
systolic right ventricular area.
Case ReportsIn retrospect, there were 2 interventions that could per-
haps have prevented this course of events. First, an atrial
septal defect could have been created before transplant,
enabling right-to-left shunting. Currently, atrial septal de-
fect creation is only considered in patients with pulmonary
hypertension who have persistent right ventricular failure
despite maximal therapy, and the procedure is oftenFIGURE 2. Hemodynamics during the hour be
e8 The Journal of Thoracic and Cardiovascular Surgeperformed as a bridge to transplant.2 The resulting in-
crease in LV preload might have offered a training period
for the LV before BLTx. Still, the correct atrial septal de-
fect size and the timing of the procedure remain highly
debatable.3
Second, the weaning process should have been more con-
trolled, to allow adaptation to the altered hemodynamicfore collapse. LVF, Left ventricular failure.
ry c January 2013
Case Reportsstatus.4 Determination of the exact timing, however, re-
mains difficult. Monitoring of PAP, pulmonary capillary
wedge pressure, and LV function before and during the
weaning process is mandatory.4
We report the case of a young man with idiopathic pul-
monary arterial hypertension who underwent urgent BLTx
for decompensation. We attribute his complicated postoper-
ative course to diastolic dysfunction in a chronically de-
prived LV in combination with an increased preload,
resulting from normalization of the PVR, and an increased
afterload during weaning. Awareness of this problem may
lead to earlier discrimination of such patients and a more
controlled weaning process after BLTx.From the Division of Thoracic Surgery,a Massachusetts General Hospital, Boston,
Mass; and the Division of Thoracic Surgery,b Mayo Clinic, Rochester, Minn.
Disclosures: Authors have nothing to disclose with regard to commercial support.
Received for publication Aug 26, 2012; accepted for publication Oct 15, 2012;
available ahead of print Nov 12, 2012.
Address for reprints: Eitan Podgaetz, MD,MPH, 7 Emerson Pl, No. 702, Boston, MA,
02114 (E-mail: epodgaetz@partners.org).
J Thorac Cardiovasc Surg 2013;145:e9-13
0022-5223/$36.00
Copyright  2013 by The American Association for Thoracic Surgery
http://dx.doi.org/10.1016/j.jtcvs.2012.10.022
The Journal of Thoracic and CWe thank Piet Claus and Maja Cikes for their valuable help re-
garding the analysis of echocardiographic images.
References
1. Vizza CD, Lynch JP, Ochoa LL, Richardson G, Trulock EP. Right and left ventric-
ular dysfunction in patients with severe pulmonary disease. Chest. 1998;113:
576-83.
2. Kerstein D, Levy PS, Hsu DT, Hordof AJ, Gersony WM, Barst RJ. Blade balloon
atrial septostomy in patients with severe primary pulmonary hypertension. Circu-
lation. 1995;91:2028-35.
3. Koeken Y, Kuijpers NH, Lumens J, Arts T, Delhaas T. Atrial septostomy benefits
severe pulmonary hypertension by increase of left ventricular preload reserve. Am
J Physiol Heart Circ Physiol. 2012;302:H2654-62.
4. B^ırsan T, Kranz A, Mares P, Artemiou O, Taghavi S, Zuckermann A, et al. Tran-
sient left ventricular failure following bilateral lung transplantation for pulmonary
hypertension. J Heart Lung Transplant. 1999;18:304-9.Esophageal complications of catheter ablation for atrial fibrillation:
A case reportEitan Podgaetz, MD, MPH,a and Claude Deschamps, MD,b Boston, Mass, and Rochester, MinnAtrial fibrillation is the most common cardiac arrhythmia. It
is commonly known as irregularly irregular because the
time elapsing between 2 consecutive R waves do not follow
a repetitive pattern and there are no distinct P waves.
Atrial fibrillation has significant morbidity and associ-
ated health care costs. Many medical and nonmedical treat-
ments exist to control atrial fibrillation. Catheter ablation of
atrial fibrillation foci is a relatively new technology to man-
age atrial fibrillation in selected patients.
Minimally invasive techniques in all fields of surgery and
medicine have blossomed with new technology and in-
creased patient interest. Long-term results are lacking and
new potential complications related to the new technologies
are now being seen.
Catheter-based therapies for atrial fibrillation are part of
the current guidelines recommended by major international
cardiovascular societies.1
Since the initial report by Ha€ınsaguerre and colleagues2
of pulmonary vein foci as initiators of atrial fibrillation in
1998, many developments have been made to ablate these
foci to eradicate atrial fibrillation. Long-term follow-upand potential complications from many of these advanced
techniques are unknown.
Circumferential pulmonary vein and left atrial ablation is
reported to be effective for paroxysmal and chronic atrial fi-
brillation.3-5 In the 2011 focused update on the management
of patients with atrial fibrillation, the American College of
Cardiology, American Heart Association, and the European
Society of Cardiology continue to recommend ablation
therapies to manage atrial fibrillation.1
The technique for catheter ablation varies by institution
and among electrophysiologists. Commonly, the proce-
dure is performed using transesophageal echocardiogram
to rule out the presence of atrial thrombi and assess ven-
tricular and valvular function. An electrode catheter in the
coronary sinus is used to record left atrial electrical activ-
ity as well as for pacing. After transseptal puncture, pa-
tients are anticoagulated with the aim to maintain an
activated clotting time of 300 seconds or greater. Different
devices exist to create lesions around the pulmonary
veins, usually 1 to 2 cm from their ostia, along the poste-
rior left atrium or roof and along the mitral isthmus.6
Catheter ablation for atrial fibrillation has a reported mor-
bidity of approximately 6%.7
Major complications after catheter ablation for atrial fibril-
lation have been reported in the cardiology, radiology, and
surgical literature.8-12 Factors identified as risk factors for
complications include multiple transseptal punctures,
prolonged and complicated sheath, catheter manipulations,
and aggressive attempts at transmural ablation (high energy
and high contact forces). The most common complication
reported are pulmonary vein stenosis (1.63%), pericardialardiovascular Surgery c Volume 145, Number 1 e9
